Standout Papers

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 2023 2026 2024140
  1. GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives (2023)
    Riccardo Nevola, Simona Imbriani et al. International Journal of Molecular Sciences
  2. Predictors of early and late hepatocellular carcinoma recurrence (2023)
    Riccardo Nevola, Maria Rosaria Alfano et al. World Journal of Gastroenterology

Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 18

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management
2024 Standout
2 intermediate papers

Works of Simona Imbriani being referenced

Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study
2022
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
2020

Author Peers

Author Last Decade Papers Cites
Simona Imbriani 154 178 42 133 13 428
V. Scafidi 115 106 10 95 14 431
Xiaolin Wang 207 54 25 138 22 436
Myoung Ju Koh 85 52 37 73 13 392
Clare A. Balendran 147 80 11 111 11 376
Mengzhen Dong 199 73 162 94 16 506
Edip Uçar 136 99 10 58 19 408
Rocío García de la Garza 82 113 6 103 14 450
Pengbo Wu 301 89 14 228 22 459
Masashi Miyao 190 46 12 155 24 492
M Hussain 196 39 58 165 13 426

All Works

Loading papers...

Rankless by CCL
2026